- Research Article
- 10.1016/j.jacc.2026.02.176
26-A-17399-ACC ROLE OF SGLT-2 INHIBITORS IN PATIENTS WITH VENTRICULAR TACHYCARDIA WITHOUT HEART FAILURE OR CARDIOMYOPATHY
- Apr 01, 2026
- JACC
- Muhammad Sabri + 2 more +2
Publications from 2021 to 2026
Showing 10 of 351 papers
26-A-17399-ACC ROLE OF SGLT-2 INHIBITORS IN PATIENTS WITH VENTRICULAR TACHYCARDIA WITHOUT HEART FAILURE OR CARDIOMYOPATHY
Abstract No. 580 Outcomes of Embolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Institution Experience
26-A-16008-ACC EXPLORING RAAS INHIBITION IN ATRIAL FIBRILLATION: IMPACT ON ABLATION OUTCOMES AND HEART FAILURE RISK
26-CCC-12601-ACC AN UNEXPECTED GI INVOLVEMENT IN THE CARDIAC-PREDOMINANT VAL122ILE HEREDITARY ATTR
Improving the resident interview process with structural and statistical bias correction
Peanut Balls for Women during Labor: An Approach to Promote Vaginal Birth.
To analyze the effect of peanut balls for labor support on the nulliparous term singleton vertex (NTSV) cesarean and overall cesarean birth rates in our maternity service. Retrospective analysis of participants from a 30-bed maternity unit discharged between January 1, 2018, and December 31, 2023. Among 4,005 participants, those who used a peanut ball ( n = 1,680) during labor were significantly younger, more likely to be nulliparous, and more likely to give birth at term compared to nonpeanut ball users. Multivariable logistic regression showed that peanut ball use was associated with increased odds of vaginal birth (OR = 1.21, 95% CI [1.03, 1.43], p = .0239), after adjusting for age, gestational age, and parity. Age and gestational age were also significant predictors of vaginal birth, whereas race was not. Using peanut balls for labor support may support vaginal birth without compromising neonatal outcomes. Education for all members of the maternity team is an important aspect of implementing peanut balls for labor support. Continued implementation and evaluation of peanut ball use, along with other labor support strategies, shows potential for improving vaginal birth rates while maintaining safe neonatal outcomes.
Read moreConservative Versus Operative Management of Pediatric Isolated Anterior Shoulder Instability: A Systematic Review and Meta-Analysis
Anterior shoulder instability, which includes dislocations and subluxations, is a significant concern in pediatric populations (≤19 years). Following an initial dislocation or subluxation, these patients often develop recurrent instability, which can result in long-term functional compromise. While timely and appropriate treatment is crucial, there remains a lack of consensus in the literature regarding the optimal management of pediatric shoulder instability. This systematic review aims to compare the efficacy of conservative and operative treatments for traumatic, isolated anterior shoulder instability in pediatric populations using recurrence of instability and return to play (RTP) at pre-injury levels as outcome measures. This study also provides a contemporary analysis that reflects evolving treatment strategies.This systematic review targeted studies published between 2013 and 2023 that evaluated pediatric patients (≤19 years), most between 13 and 19 years of age, who received conservative or operative treatment for a first-time or recurrent traumatic isolated anterior shoulder dislocation or subluxation. Statistical analysis was performed to compare rates of recurrence of instability and RTP within each group. Pooled effects (odds ratios) were estimated using fixed-effects models where heterogeneity was absent; otherwise, random-effects models were applied.A total of 1,459 patients (1,468 shoulders) met the inclusion criteria. Of these, 593 (40.4%) underwent conservative treatment, while 885 (60.3%) received operative interventions. Recurrence rates of instability were higher in the conservative group (236/543, 43.5%) compared to the primary operative group (182/875, 20.8%) and secondary operative group (2/26, 7.7%). RTP rates included 145/193 (75.1%) of conservatively treated patients, 380/480 (79.2%) of primary operative patients, and 8/11 (72.7%) of secondary operative patients returning to pre-injury levels. Among the four studies that directly compared conservative and primary operative treatments, the nonoperative group was more likely to have recurrence compared to the primary operative group (OR = 6.90; 95% CI, 2.28-20.91; p < 0.001). One of these studies was excluded due to methodological differences. A subsequent meta-analysis revealed a significantly higher likelihood of recurrent instability in conservatively treated patients (odds ratio (OR) = 9.55; 95% confidence interval (CI): 5.10-17.88; p < 0.001). In contrast, there was no statistically significant difference in RTP between groups (OR = 3.11; 95% CI: 0.31-30.97; p = 0.33).The findings support early surgical intervention in pediatric patients to reduce recurrence and improve functional outcomes. Conservative management, while recently shown to be successful for patients with less severe injuries such as subluxations, is still primarily associated with higher recurrence rates compared to operative treatment. Further studies are needed to refine treatment protocols by distinguishing effective strategies for subluxations versus dislocations. Future research should also explore the influence of factors such as sex, skeletal maturity, and activity level in determining optimal management strategies in pediatric patients.
Read moreAlterations of right ventricular assessment by use of an ultrasound-enhancing agent during routine visualization of the left ventricle.
Two-dimensional echocardiography remains the primary means of right ventricular (RV) evaluation. This study evaluated effects of ultrasound contrast, employed to improve left ventricular (LV) visualization, on assessment of RV size and function. In 100 consecutive patients where an ultrasound enhancing agent (UEA) was indicated to improve LV visualization, apical 4-chamber (A4C) views were collected before and after contrast injection, maintaining transducer position. For the last 50 subjects, RV-focused (RVF) views were also obtained. Images were presented in random order to four echocardiographers with varying levels of experience. They were tasked with determining which ventricle formed the apex, whether the RV free wall was adequately visualized, assessing RV size and contractility and reporting their confidence level in their readings. In both A4C and RVF views, the LV was less often determined to be apex-forming when UEA was used and RV size assessments moved in the direction of dilated for all readers. Similarly, a determination of reduced RV contractility occurred more often with UEA. Many of these differences were statistically significant. Interestingly, RV free wall visualization was not improved with contrast use. Moreover, reader confidence in interpretation was actually reduced when contrast was employed, with statistically significant differences for all four readers in the A4C view and two readers in the RVF view. Opportunistic evaluation of the RV after employing UEA resulted in significant differences in visual assessment of various RV parameters. Reader confidence in interpretation was not improved when contrast was used.
Read moreImpact of glucagon-like peptide-1 receptor agonists on clinical outcomes in pancreatic cancer: A large-scale real-world cohort study.
688 Background: Pancreatic cancer is one of the leading causes of cancer-related death and is associated with poor overall survival. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely prescribed for diabetes and obesity, have been investigated for potential impact in patients with pancreatic cancer, although their safety and clinical effects remain uncertain. This study evaluates the association between GLP-1RA use and clinical outcomes in a real-world cohort of patients with pancreatic cancer. Methods: Using the TriNetX Network database (72 healthcare organizations), we identified patients with pancreatic cancer who were prescribed GLP-1 receptor agonists (GLP-1RAs; n = 1,972) from 2010 to 2022, and matched controls without exposure to GLP-1RAs (n = 57,645). Propensity score matching balanced demographics and comorbidities, yielding 1,821 patients in each group. The primary outcomes were all-cause mortality and overall survival, assessed with Kaplan–Meier survival curves. Secondary outcomes included hospitalization, postoperative infection/sepsis, venous thromboembolism (VTE), acute kidney injury (AKI), and chronic kidney disease (CKD). Risk ratios (RRs) with 95% confidence intervals were estimated over a three-year follow-up period. Results: After propensity matching, the mean age was 72.0 years in the GLP-1RA group and 71.8 years in the non-GLP-1RA group. GLP-1RA users had lower all-cause mortality compared with non-users (40.6% vs 44.3%; risk ratio [RR] 0.92, 95% CI 0.85–0.99; p = 0.025) and longer median survival (1,065 vs 824 days; hazard ratio [HR] 0.90, 95% CI 0.81–0.997; p = 0.043). Hospitalization was less frequent in GLP-1RA users (40.2% vs 46.1%; RR 0.87; p = 0.040). Postoperative infection/sepsis (18.1% vs 21.3%; RR 0.85; p = 0.023) was also significantly lower in the GLP-1RA group. No significant differences were observed for VTE (15.1% vs 16.4%; p = 0.335), AKI (18.7% vs 20.2%; p = 0.317), or CKD (10.4% vs 8.4%; p = 0.073). Conclusions: GLP-1RA use was associated with lower mortality, longer survival, and reduced risks of hospitalization and postoperative infection/sepsis in patients with pancreatic cancer, without increased risk of VTE or renal complications. Prospective studies are warranted to confirm these findings and further clarify the role of GLP-1RAs in pancreatic cancer care.
Read moreImpacts of Mitral Annular Calcification on Heart Failure With Preserved Ejection Fraction.
Mitral annular calcification (MAC) and heart failure with preserved ejection fraction (HFpEF) share risk factors but links between the 2 have not been well studied. Using data from the TriNetX US Collaborative Network various cohorts were created which were propensity score matched (by demographics and comorbidities) and used to perform 3 studies: 1) All hospitalized patients between 2020 and 2023, without prior heart failure, were stratified by presence or absence of MAC to assess risk of developing HFpEF at 1 year. 2) Patients with a HFpEF diagnosis were stratified by presence or absence of a new diagnosis of MAC between 2020 and 2023 and evaluated for cardiovascular outcomes at 1 year. 3) Data from study-1 were further explored for interactions between MAC and body-mass index (BMI) in development of HFpEF at 1 year. In study-1, MAC patients were at higher risk of developing HFpEF versus no-MAC (HR 3.80, p < 0.0001). In study-2, HFpEF patients with vs without MAC were at higher risk of HF hospitalization (HR 1.24, p < 0.0001), all-cause hospitalization (HR 1.34, p < 0.0001), and various cardiovascular outcomes. In study-3, incident HFpEF in the no-MAC group was low with a "J-shaped" curve noted across BMI quintiles. MAC patients had a much higher incidence of HFpEF with little influence of BMI except in the highest quintile. In conclusion: MAC is an independent risk factor for development of HFpEF. When present in HFpEF patients, there is increased risk of re-hospitalization and cardiovascular events. MAC has much greater impact on development of HFpEF than does BMI.
Read more